A comparative study on the pharmacokinetics of methotrexate in a dose range of 0.5 g to 33.6 g/m2 in children with acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

A comparative study on the pharmacokinetics of methotrexate in a dose range of 0.5 g to 33.6 g/m2 in children with acute lymphoblastic leukemia

Published:1987-07-01 Issue:1 Volume:60 Page:5-13
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Borsi Joseph D.,Moe Peter Johan

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference31 articles.

1. Pharmacologic Principles of Cancer Treatment. Philadelphia: WB Saunders, 1982; 229–255.

2. INTERMEDIATE DOSE METHOTREXATE (IDM) IN CHILDHOOD ACUTE LYMPHOCYTIC LEUKEMIA IN NORWAY.

3. Intermediate dose methotrexate in childhood acute lymphocytic leukemia

4. , , . The Norwegian Methotrexate Study in childhood acute lymphocytic leukemia. In: , , eds. Central Nervous System Leukemia. Boston: Martinas Nijhoff Publishing, 1983; 65–69.

5. , et al. High dose MTX therapy 6–8 g/m2) in childhood malignancies: Toxicity and pharmacokinetics. Paediatr Haematol Oncol 1987 (accepted for publication).

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Folinic Acid Over: Rescue of Intermediate Dose Methotrexate;Clinical Lymphoma Myeloma and Leukemia;2023-12

2. Factors influencing methotrexate pharmacokinetics highlight the need for individualized dose adjustment: a systematic review;European Journal of Clinical Pharmacology;2023-11-07

3. Early clinical indicators of acute kidney injury caused by administering high-dose methotrexate therapy to juvenile pigs;Frontiers in Nephrology;2023-09-12

4. Comparison of differing dose levels of methotrexate for patients with primary central nervous system lymphoma;Journal of Oncology Pharmacy Practice;2023-05-17

5. A Systematic Review of High-Dose Methotrexate for Adults with Primary Central Nervous System Lymphoma;Cancers;2023-02-25